跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BLENREP POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG - PPB Drug Approval Details
Approvals
/
PPB
/
BLENREP POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG
Approved
STANDARD
BLENREP POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG
葛兰素史克
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
c9cb5aa62f3f4ea6
Company
葛兰素史克
Type
Standard
Approval Details
Approval Id
c9cb5aa62f3f4ea6
Product Name
BLENREP POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG
Drug Hk Name
BLENREP POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG
Registration Code
HK-67213
Company Name
葛兰素史克
Company Detail Path
/organization/glaxosmithkline
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2021-09-27
Company Address
23/F, TOWER 6, THE GATEWAY, 9 CANTON ROAD, TSIM SHA TSUI, KOWLOON
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
c9cb5aa62f3f4ea6
Type
Standard
Back to PPB Approvals